Tradestie Institutional Equity Comparison Engine

EQ vs ECOR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EQ Overall Edge

EQ Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EQ trades at 1.5x Forward P/E with 0.0% operating margin (-52.3% YoY revenue) versus ECOR at N/M Forward P/E and -33.1% operating margin (+11.5% YoY). In options structure, EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner EQ
EQ 1.5x vs ECOR N/M Fwd P/E
Growth & Margin Winner EQ
Op Margin 0.0% vs -33.1% ยท YoY -52.3% vs +11.5%
Momentum & Technical Winner EQ
1Y +12.0% vs -4.0% ยท 52W Pos 11% vs 6%
Options & Structure Winner EQ
UNCLASSIFIED (100th %ile IV) vs UNCLASSIFIED (N/A IV)
EQ NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap $90.6M
1M Return -21.13%
1Y Return +12.0%
Forward P/E 1.5x
Unified AI Score
48.0 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 63.0 Mom 60.0
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EQ +12.0% ECOR -3.96% Spread: +15.96 pp (EQ Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period EQ Revenue ECOR Revenue EQ Op. Margin ECOR Op. Margin Margin Edge
FY2018 N/A $0M N/A -5494.1% ECOR
FY2019 N/A $0M N/A -1928.2% ECOR
FY2020 N/A $0M N/A -707.9% ECOR
FY2021 N/A $10M N/A -367.7% ECOR
FY2022 $20M $10M -393.9% -266.2% ECOR
FY2023 $40M $20M -40.2% -120.2% EQ
FY2024 $40M $30M -20.1% -48.3% EQ
FY2025 N/A $30M N/A -41.1% ECOR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EQ (8) vs ECOR (2)
Institutional Metric EQ ECOR Criterion Row Winner
Market Capitalization Scale $90.6M $47.7M Larger Scale EQ
Trailing P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Forward P/E Ratio Valuation 1.5x N/M Lower Multiple EQ
Revenue Growth (YoY) Growth -52.3% +11.5% Higher Growth ECOR
Operating Margin (TTM) Profitability 0.0% -33.1% Higher Margin EQ
Net Profit Margin Profitability 0.0% -33.5% Higher Margin EQ
Return on Equity (ROE) Capital Efficiency -59.0% -478.7% Higher ROE EQ
52-Week Range Position Momentum 11% ($1โ€“$4) 6% ($4โ€“$13) Stronger Trend EQ
Beta / 30D Volatility Risk Regime 1.53ฮฒ ยท 93% Vol 1.52ฮฒ ยท 155% Vol Lower Realized Risk EQ
Unified Institutional Score Composite Signal 48.0 / 100 (HOLD) 56.8 / 100 (HOLD) Higher Composite ECOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EQ vs ECOR Buy Guide
EQ UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live EQ Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EQ nor ECOR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.